California Walnut Commission   Report issue

Government Phase 2
Founded: Folsom CA United States (1948)

Organization Overview

First Clinical Trial
2007
NCT00525629
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

California Walnut Commission

Active Ingredients

Drugs in Phase 2 Trials (1)

walnut (11 trials)

Drugs in Other Trials (1)

walnut oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 2)

Metabolic Syndrome (Phase 2)

Prostatic Neoplasms (Phase 2)

Syndrome (Phase 2)

Weight Loss (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 11
  • # of Trial APIs: 2